Cargando…
Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. MET...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094140/ https://www.ncbi.nlm.nih.gov/pubmed/27806732 http://dx.doi.org/10.1186/s40249-016-0195-9 |
_version_ | 1782465070083604480 |
---|---|
author | Ji, Ying-Jie Duan, Xue-Zhang Gao, Xu-Dong Li, Lei Li, Chen Ji, Dong Li, Wen-Gang Wang, Li-Fu Meng, Yu-Hua Yang, Xiao Ling, Bin-Fang Song, Xue-Ai Gu, Mei-Lei Jiang, Tao Koroma, She-Ku M. Bangalie, James Duan, Hui-Juan |
author_facet | Ji, Ying-Jie Duan, Xue-Zhang Gao, Xu-Dong Li, Lei Li, Chen Ji, Dong Li, Wen-Gang Wang, Li-Fu Meng, Yu-Hua Yang, Xiao Ling, Bin-Fang Song, Xue-Ai Gu, Mei-Lei Jiang, Tao Koroma, She-Ku M. Bangalie, James Duan, Hui-Juan |
author_sort | Ji, Ying-Jie |
collection | PubMed |
description | BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. METHODS: The study admitted 285 patients with confirmed EVD and followed them up till the endpoint (recovery or death). EVD was confirmed by quantitative RT-PCR assays detecting blood Ebola virus (EBOV). RESULTS: Among the 285 lab-confirmed EVD cases in Jui Government Hospital, 146 recovered and 139 died, with an overall survival rate of 51.23 %. Patients under the age of 6 years had a lower survival rate (37.50 %). Most non-survivors (79.86 %) died within 7 days after admission and the mean hospitalization time for non-survivors was 5.56 ± 6.11 days. More than half survivors (63.69 %) turned blood EBOV negative within 3 weeks after admission and the mean hospitalization time for survivors was 20.38 ± 7.58 days. High blood viral load (≥10(6) copies/ml) was found to be predictive of the non-survival outcome as indicated by the Receiver Operating Characteristic (ROC) curve analysis. The probability of patients’ survival was less than 15 % when blood viral load was greater than 10(6) copies/ml. Multivariate analyses showed that blood viral load (P = 0.005), confusion (P = 0.010), abdominal pain (P = 0.003), conjunctivitis (P = 0.035), and vomiting (P = 0.004) were factors independently associated with the outcomes of EVD patients. CONCLUSIONS: Most death occurred within 1 week after admission, and patients at the age of 6 or younger had a lower survival rate. Most surviving patients turned blood EBOV negative within 1–4 weeks after admission. Factors such as high blood viral load, confusion, abdominal pain, vomiting and conjunctivitis were associated with poor prognosis for EVD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40249-016-0195-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5094140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50941402016-11-07 Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone Ji, Ying-Jie Duan, Xue-Zhang Gao, Xu-Dong Li, Lei Li, Chen Ji, Dong Li, Wen-Gang Wang, Li-Fu Meng, Yu-Hua Yang, Xiao Ling, Bin-Fang Song, Xue-Ai Gu, Mei-Lei Jiang, Tao Koroma, She-Ku M. Bangalie, James Duan, Hui-Juan Infect Dis Poverty Research Article BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. METHODS: The study admitted 285 patients with confirmed EVD and followed them up till the endpoint (recovery or death). EVD was confirmed by quantitative RT-PCR assays detecting blood Ebola virus (EBOV). RESULTS: Among the 285 lab-confirmed EVD cases in Jui Government Hospital, 146 recovered and 139 died, with an overall survival rate of 51.23 %. Patients under the age of 6 years had a lower survival rate (37.50 %). Most non-survivors (79.86 %) died within 7 days after admission and the mean hospitalization time for non-survivors was 5.56 ± 6.11 days. More than half survivors (63.69 %) turned blood EBOV negative within 3 weeks after admission and the mean hospitalization time for survivors was 20.38 ± 7.58 days. High blood viral load (≥10(6) copies/ml) was found to be predictive of the non-survival outcome as indicated by the Receiver Operating Characteristic (ROC) curve analysis. The probability of patients’ survival was less than 15 % when blood viral load was greater than 10(6) copies/ml. Multivariate analyses showed that blood viral load (P = 0.005), confusion (P = 0.010), abdominal pain (P = 0.003), conjunctivitis (P = 0.035), and vomiting (P = 0.004) were factors independently associated with the outcomes of EVD patients. CONCLUSIONS: Most death occurred within 1 week after admission, and patients at the age of 6 or younger had a lower survival rate. Most surviving patients turned blood EBOV negative within 1–4 weeks after admission. Factors such as high blood viral load, confusion, abdominal pain, vomiting and conjunctivitis were associated with poor prognosis for EVD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40249-016-0195-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-03 /pmc/articles/PMC5094140/ /pubmed/27806732 http://dx.doi.org/10.1186/s40249-016-0195-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ji, Ying-Jie Duan, Xue-Zhang Gao, Xu-Dong Li, Lei Li, Chen Ji, Dong Li, Wen-Gang Wang, Li-Fu Meng, Yu-Hua Yang, Xiao Ling, Bin-Fang Song, Xue-Ai Gu, Mei-Lei Jiang, Tao Koroma, She-Ku M. Bangalie, James Duan, Hui-Juan Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title_full | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title_fullStr | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title_full_unstemmed | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title_short | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone |
title_sort | clinical presentations and outcomes of patients with ebola virus disease in freetown, sierra leone |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094140/ https://www.ncbi.nlm.nih.gov/pubmed/27806732 http://dx.doi.org/10.1186/s40249-016-0195-9 |
work_keys_str_mv | AT jiyingjie clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT duanxuezhang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT gaoxudong clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT lilei clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT lichen clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT jidong clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT liwengang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT wanglifu clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT mengyuhua clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT yangxiao clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT lingbinfang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT songxueai clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT gumeilei clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT jiangtao clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT koromashekum clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT bangaliejames clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone AT duanhuijuan clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone |